Newsroom

The latest announcements from Predictive Technology Group.

Predictive Technology Group and Manufacturing Partners Provide Updates of Its Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point of Care

Company provides formal response to misleading recently published short report SALT LAKE CITY, March 30, 2020 (GLOBE NEWSWIRE) — Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), a leader in the development of genetic and molecular diagnostics and companion therapeutics, and its manufacturing partner, Jiangsu Dablood Pharmaceutical CO, Ltd. (Dablood), a partner entity […]

Predictive Technology Group Announces Launch of Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point of Care

Assurance AB™ is a single-use, self-contained SARS-CoV-2 (COVID-19) antibody detection test that provides results in 15-minutes. SALT LAKE CITY, March 25, 2020 (GLOBE NEWSWIRE) — Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), a leader in the development of genetic and molecular diagnostics and companion therapeutics today announced that in response to the […]

Predictive Technology Group Addresses Use of Mesenchymal Stem Cells in Treatment of Secondary Issues Related to Coronavirus

SALT LAKE CITY, March 17, 2020 (GLOBE NEWSWIRE) — Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), today announced that last week it began communication with domestic and international agencies and groups to be a supplier of mesenchymal stem cells (MSCs) for the potential clinical treatment of patients suffering from secondary issues related to the […]

Atrin Pharmaceuticals Adds Critical Genomics Capabilities in Advance of Initiating First Clinical Trial Through Ongoing Collaboration with Predictive Technology Group

Doylestown, PA – February 25, 2020 – Atrin Pharmaceuticals, a private biopharmaceutical company pioneering the discovery and development of proprietary molecules targeting DNA Damage and Repair (DDR) pathways to treat cancers that currently do not have effective therapies, today reported preliminary results from a collaborative genomics analysis that will be used to optimize patient selection […]

Empowered Patient Podcast with Karen Jagoda.

Our CEO, Brad Robinson, was featured on Karen Jagoda’s Empowered Patient Podcast to discuss our work in women’s health and the importance of genetics in informing a woman’s course of care. Brad also explains how our subsidiaries work together in helping women and their clinicians address endometriosis and other reproductive health concerns. Listen here: https://bit.ly/2SClJ2k

Predictive Technology Group Announces Beta Test Results for its ARTguide™ Test

SALT LAKE CITY (February 11, 2020) Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), a leader in helping identify barriers that impact women’s health and build healthier families through its innovations to deliver personalized medicine, today announced that its wholly owned subsidiary, Predictive Laboratories, received interim beta test results from its ARTguide™ test […]

Predictive Technology Group and Atrin Pharmaceuticals Announce Molecular Diagnostic Oncology Development Collaboration

SALT LAKE CITY (January 28, 2020) Predictive Technology Group (OTC PINK: PRED) and Atrin Pharmaceuticals LLC are entering into a collaboration agreement to develop molecular diagnostic tools to facilitate improved selection of cancer patients who would most benefit from treatment with DNA Damage and Response (DDR) inhibitors, including Atrin’s and other small molecule ATR inhibitors. […]

Scrip

Scrip Asks… What Does 2020 Hold For Biopharma? Part 4: The Patient Pharma Is Getting More Personal https://scrip.pharmaintelligence.informa.com/SC141458/Scrip-Asks-What-Does-2020-Hold-For-Biopharma-Part-4-The-Patient  

Simplemost

There’s A Non-Invasive Procedure That Can Lighten Heavy Periods https://www.simplemost.com/endometrial-ablation-can-lighten-heavy-periods